Home / Stocks / CRVS

CRVS insider trading

Corvus Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$334k
Buys · last 90 days
1 · $250k
Most recent buy
2026-06-15

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-15Moore David Scott
Director
Bought21,700$11.53$250k
2026-05-20MILLER RICHARD A MD
President and CEO
Bought6,932$12.04$83k
2025-07-01ORBIMED ADVISORS LLC
Director · 10% owner
Sold1,176,332$4.16$4.9M
2025-07-01Thompson Peter A.
Director · 10% owner
Sold1,176,332$4.16$4.9M

Most active insider buyers

InsiderRoleBuysTotal bought
Moore David ScottDirector1$250k
MILLER RICHARD A MDPresident and CEO1$83k

See CRVS on the chart

Every insider buy and sell for CRVS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.